Expanded newborn screening: Articulating the ontology of diseases with bridging work in the clinic

Sociology of Health and Illness

Volumn 34, Issue 2, 2012, Pages 208-220

  Timmermans, Stefan ^a   Buchbinder, Mara ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Ethnography; Genetics; Medical technologies; Screening; Uncertainty

Indexed keywords

ARTICLE; GENETIC SCREENING; GENETICS; HUMAN; KNOWLEDGE; METABOLIC DISORDER; METHODOLOGY; NEWBORN; NEWBORN SCREENING; SECONDARY PREVENTION; TIME; UNCERTAINTY; UNITED STATES;

CALIFORNIA; GENETIC TESTING; HUMANS; INFANT, NEWBORN; KNOWLEDGE; METABOLIC DISEASES; NEONATAL SCREENING; SECONDARY PREVENTION; TIME FACTORS; UNCERTAINTY;

EID: 84857501483     PISSN: 01419889     EISSN: 14679566     Source Type: Journal    
DOI: 10.1111/j.1467-9566.2011.01398.x     Document Type: Article

References (35)

1. Akrich, M. (1992) The de-scription of technical objects. In Bijker, W. and Law, J. (eds) Shaping Technology/Building Society: Studies in Sociotechnical Change. Cambridge: MIT Press.
2. Andresen, B.S., Dobrowolski, S.F., O'Reilly, L., Muenzer, J., McCandless, S.E., et al. (2001) Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency, American Journal of Human Genetics, 68, 6, 1408-18.
3. Armstrong, D. (1979) Child development and medical ontology, Social Science and Medicine, 13, 1, 9-12.
4. Aronowitz, R.A. (2008) Framing disease: an underappreciated mechanism for the social patterning of health, Social Science and Medicine, 67, 1, 1-9.
5. Bowker, G. and Star, S.L. (1999) Sorting Things Out. Cambridge: MIT Press.
6. Buchbinder, M. and Timmermans, S. (2011) Medical technologies and the dream of the perfect newborn, Medical Anthropology, 30, 1, 56-80.
7. Epstein, S. (1996) Impure Science: AIDS, Activism, and the Politics of Knowledge. Berkeley: University of California Press.
8. Greene, J.A. (2007) Prescribing by Numbers. Baltimore: Johns Hopkins University Press.
9. Gregersen, N., Winter, V., Curtis, D., Deufel, T., et al. (1993) Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: the prevalent mutation G985 (K304E) is subject to a strong founder effect from northwestern Europe, Human Heredity, 43, 6, 342-50.
10. Hedgecoe, A. (2004) The Politics of Personalized Medicine, Cambridge: Cambridge University Press.
11. Iafolla, A.K., Thompson, R.J. and Roe, C.R. (1994) Medium-chain acyl-coenzyme A dehydrogenase deficiency: Clinical course in 120 affected children, Journal of Pediatrics, 124, 3, 409-15.
12. Kerr, A. (2005) Understanding genetic disease in a socio-historical context: A case study of cystic fibrosis, Sociology of Health and Illness, 27, 7, 873-96.
13. Kirk, S.A. and Kutchins, H. (1992) The Selling of the DSM: the Rhetoric of Science in Psychiatry. Hawthorne: Aldine De Gruyter.
14. Kuhn, T. (1962) The Structure of Scientific Revolutions. Chicago: University of Chicago Press.
15. Lakoff, A. (2005) Pharmaceutical Reason: Knowledge and Value in Global Psychiatry. Cambridge: Cambridge University Press.
16. Latimer, J., Featherstone, K., Atkinson, P., Clarke, A., et al. (2006) Rebirthing the clinic: the interaction of clinical judgment and genetic technology in the production of medical science, Science, Technology, and Human Values, 31, 5, 599-630.
17. Maier, E.M., Liebl, B., Roschinger, W., Nennstiel-Ratzel, U., et al. (2005) Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency, Human Mutation, 25, 5, 443-52.
18. Mol, A. (2002) The Body Multiple: Ontology in Medical Practice. Durham: Duke University Press.
19. Paul, D.B. (1997) The history of newborn phenylketonuria screening in the US. In Holtzman, N.A. and Watson, M.S. (eds) Promoting Safe and Effective Genetic Testing in the United States: Final Report of the Taskforce on Genetic Testing. Bethesda, MD: National Institutes of Health.
20. Rabeharisoa, V. and Bourret, P. (2009) Staging and weighting evidence in biomedicine: comparing clinical practices in cancer genetics and psychiatric genetics, Social Studies of Science, 39, 5, 691-715.
21. Rose, G. (1992) Strategy of Preventive Medicine. Oxford: Oxford University Press.
22. Rosenberg, C.E. (2007) Our Present Complaint: American Medicine. Then and Now. Baltimore: Johns Hopkins University Press.
23. Schutz, A. (1967) The Phenomenology of the Social World. Evanston: Northwestern University Press.
24. Smith, E.H., Thomas, C., McHugh, D., Gavrilov, D., et al. (2010) Allelic diversity in MCAD deficiency: the biochemical classification of 54 variants identified during 5years of ACADM sequencing, Molecular Genetics and Metabolism, 100, 3, 241-50.
25. Star, S.L. (1995) Ecologies of Knowledge. Albany: State University of New York Press.
26. Timmermans, S. and Berg, M. (2003a) The Gold Standard: The Challenge of Evidence-Based Medicine and Standardization in Health Care. Philadelphia: Temple University Press.
27. Timmermans, S. and Berg, M. (2003b) The practice of medical technology, Sociology of Health and Illness, 25, Silver Anniversary Issue, 97-114.
28. Timmermans, S. and Buchbinder, M. (2010) Patients-in-waiting: living between sickness and health in the genomics era, Journal of Health and Social Behavior, 51, 4, 408-23.
29. Timmermans, S. and Tavory, I. (2007) Advancing ethnographic research through grounded theory practice. In Bryant, A. and Charmaz, K. (eds) Handbook of Grounded Theory. London: Sage.
30. Waddell, L., Wiley, V., Capenter, K., Bennetts, B., et al. (2006) Medium-chain acyl-COA dehydrogenase deficiency: Genotype-biochemical phenotype correlations, Molecular Genetics and Metabolism, 87, 32-9.
31. Wailoo, K. and Pemberton, K. (2006) The Troubled Dream of Genetic Medicine. Baltimore: Johns Hopkins University Press.
32. Watson, M.S., Lloyd-Puryear, M.A., Mann, M.Y., Ronaldo, P., et al. (2006) Newborn screening: toward a uniform screening panel and system, Genetics in Medicine, 8, 5, Suppl., 12S-53S.
33. Wilcken, B. (2010) Fatty acid oxydation disorders: outcome and long-term prognosis, Journal of Inherited Metabolic Disease, 33, 5, 501-6.
34. Wilson, J.M.G. and Jungner, G. (1968) Principles and Practice of Screening for Disease. Geneva: WHO.
35. Yusopov, R., Finegold, D.N., Naylor, E.W., Sahai, I., et al. (2010) Sudden death in medium chain acyl-coenzyme A dehydrogenase deficiency (MCADD) despite newborn screening, Molecular Genetics and Metabolism, 101, 1, 33-9.